Our Take
The math is backward: diagnostic imaging staff shortage (16 million) would solve 7.61% of mortality, while nurses (65 million) solve an unspecified fraction—the largest workforce gap does not match the largest clinical impact.
Why it matters
Low- and middle-income countries in Africa and Asia face survival rates 25–35 percentage points below North America. Workforce planning that ignores clinical ROI per role will waste training resources on the wrong cadres.
Do this week
Cancer care administrators: audit your diagnostic imaging pipeline against the 7.61% mortality reduction lever before hiring additional nursing staff to match developed-country ratios.
100 million cancer workers projected missing by 2050
A Lancet Oncology Commission report published in June 2025 projects a global cancer workforce shortage of approximately 100 million workers by 2050 (per the study authors from Harvard T.H. Chan School of Public Health, La Trobe University, and University of São Paulo). The analysis spans 55 countries, including South Asia, Africa, and Central America.
Nurses will account for 65 million of the shortage (per the commission report), with diagnostic and radiology/pathology specialists making up 16 million. The shortages will concentrate in Africa and Asia, regions already facing the lowest five-year survival rates for cancer patients: 34.4% in Africa and 38.7% in Asia, compared to 63.9% in North America and over 70% in Oceania.
The commission modeled the impact of scaling different workforce categories. Expanding diagnostic and imaging personnel would yield the largest mortality reduction at 7.61% (per the report). Scaling surgeons would cut mortality by 3.64%, particularly in Africa, Asia, and Oceania. A comprehensive scale-up across all workforce levels was projected to reduce cancer mortality by over 50% in the 55 countries studied, potentially averting 170 million deaths between 2030 and 2050.
The economic case: the authors estimate a return of $4 per $1 invested in workforce and diagnostic expansion, translating to $120 trillion in economic benefit over 20 years (per the commission analysis).
Largest workforce shortage does not drive largest mortality gain
The report's central finding creates a planning trap. Nursing accounts for 65% of the projected shortage (65 of 100 million roles), yet the commission does not quantify the mortality reduction attributable to nurse scaling alone. Diagnostic personnel represent only 16% of the shortage but deliver the single largest mortality benefit at 7.61%.
This inversion matters because training pipelines respond to supply forecasts, not impact metrics. A country that hires based on the headline shortage numbers will flood the market with nursing staff while starving radiology and pathology programs. The commission calls for "urgent national and global action" including workforce planning and targeted investment, but does not specify how to weight training budgets across roles.
The survival gap between high- and low-income regions (25–35 percentage points) is real and urgent. But closing it requires precision. Africa and Asia need diagnostic imaging capacity first, then supportive clinical roles scaled to match. The commission's own data suggests the field has been asking the wrong question: not "how many workers" but "how many of which workers, in which order."
Align training investment to clinical leverage, not headcount forecasts
Health administrators and workforce planners should cross-reference the commission's mortality impact rankings against local capacity gaps. If diagnostic imaging already meets or exceeds regional needs, nursing and allied health training can scale. If imaging is the bottleneck (likely in low-resource settings), that gets first funding and recruitment effort, even if nurse shortages loom larger in absolute numbers.
Establish or strengthen cancer registries and diagnostic capacity audits now. The commission calls for "workforce and cancer registries" and "cross-sector partnerships" to improve access to training and equipment. Without baseline data on current imaging throughput and turnaround times by region, scaling decisions will repeat the shortage problem rather than solve it.